Free Trial

BlackRock Capital Allocation Term Trust Announces Monthly Dividend of $0.26 (NYSE:BCAT)

BlackRock Capital Allocation Term Trust logo with Manufacturing background
Image from MarketBeat Media, LLC.

Key Points

  • Monthly dividend of $0.2607 declared; shareholders of record on March 13 will be paid on March 31, implying an annualized yield of 20.7% (ex-dividend date March 13).
  • BCAT traded down 0.4% to $15.12 midday with volume 194,506 (vs. average 770,513), trading near its one-year high of $15.41 and above its 50- and 200-day moving averages ($14.79 and $14.67).
  • BlackRock Capital Allocation Term Trust is a closed-end term fund targeting high current income and total return through an actively managed, multi-sector mix of corporate debt, floating-rate loans, convertibles, equity and structured credit, with institutional investors holding about 36.1% of shares.
  • Five stocks we like better than BlackRock Capital Allocation Term Trust.

BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) declared a monthly dividend on Friday, January 2nd. Investors of record on Friday, March 13th will be paid a dividend of 0.2607 per share on Tuesday, March 31st. This represents a c) annualized dividend and a yield of 20.7%. The ex-dividend date is Friday, March 13th.

BlackRock Capital Allocation Term Trust Stock Down 0.4%

NYSE:BCAT traded down $0.06 during midday trading on Wednesday, hitting $15.12. The stock had a trading volume of 194,506 shares, compared to its average volume of 770,513. The stock has a 50-day moving average of $14.79 and a 200 day moving average of $14.67. BlackRock Capital Allocation Term Trust has a one year low of $12.91 and a one year high of $15.41.

Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Keener Financial Planning LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at $29,000. Geneos Wealth Management Inc. lifted its stake in BlackRock Capital Allocation Term Trust by 341.7% in the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company's stock worth $31,000 after acquiring an additional 1,582 shares during the period. N.E.W. Advisory Services LLC grew its holdings in BlackRock Capital Allocation Term Trust by 100.0% during the 4th quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company's stock worth $34,000 after acquiring an additional 1,200 shares in the last quarter. AdvisorNet Financial Inc grew its holdings in BlackRock Capital Allocation Term Trust by 53.8% during the 3rd quarter. AdvisorNet Financial Inc now owns 2,995 shares of the company's stock worth $44,000 after acquiring an additional 1,048 shares in the last quarter. Finally, McIlrath & Eck LLC increased its position in BlackRock Capital Allocation Term Trust by 971.1% during the 3rd quarter. McIlrath & Eck LLC now owns 2,999 shares of the company's stock valued at $44,000 after purchasing an additional 2,719 shares during the period. Institutional investors own 36.12% of the company's stock.

About BlackRock Capital Allocation Term Trust

(Get Free Report)

BlackRock Capital Allocation Term Trust NYSE: BCAT is a closed-end, diversified management investment company organized as a term trust. The fund's primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

Featured Articles

Dividend History for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BlackRock Capital Allocation Term Trust Right Now?

Before you consider BlackRock Capital Allocation Term Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock Capital Allocation Term Trust wasn't on the list.

While BlackRock Capital Allocation Term Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines